Pricing Log in Create free account

IDEAYA Biosciences, Inc. (IDYA) vs Tarsus Pharmaceuticals, Inc. (TARS)

IDEAYA Biosciences, Inc. and Tarsus Pharmaceuticals, Inc. are both Biotechnology companies. Tarsus Pharmaceuticals, Inc. is the larger, with a market value of $3.3B against $3.0B — 1.1× the size. Tarsus Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 86.3% against −83.6%. Tarsus Pharmaceuticals, Inc. has the higher net margin (−102.9% vs −1,149.6%) and the higher return on invested capital (0.00% vs −114.2%). Across the 17 metrics below, IDEAYA Biosciences, Inc. leads on 9 and Tarsus Pharmaceuticals, Inc. on 8.

Valuation

Metric IDYA TARS Biotechnology median
P/E n/m n/m 10.26
P/S 86.70 4.59 9.18
P/B 2.90 30.12 2.05
Price to free cash flow n/m 133.67 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 63.75 4.25 8.98
Earnings yield (14.60%) (22.50%) (34.89%)
Free cash flow yield (11.04%) 0.75% (24.52%)

Profitability

Metric IDYA TARS Biotechnology median
Gross margin 100.00% 93.21% 65.16%
Operating margin (1,267.38%) (102.04%) 0.00%
Net margin (1,149.62%) (102.93%) 0.00%
Free cash flow margin (957.43%) 4.76% 0.00%
Return on equity (38.46%) (319.84%) (50.12%)
Return on assets (34.98%) (135.04%) (45.60%)
Return on invested capital (114.15%) 0.00% 0.00%

Growth

Metric IDYA TARS Biotechnology median
Revenue growth (TTM) (83.64%) 86.34% 6.26%
EPS growth (last fiscal year) 61.90% 48.21% 29.88%
Revenue growth, 5-year CAGR 62.11% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IDYA TARS Biotechnology median
Debt to equity 0.00 0.70 0.00
Current ratio 9.04 1.96 4.89
Net debt to EBITDA 3.88 4.66 1.01

Dividend

Metric IDYA TARS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IDYA TARS Biotechnology median
Market cap 2.96b 3.33b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack